|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6900 CAD | -8.00% |
|
-2.82% | -14.81% |
| Capitalization | 4.75Cr 3.47Cr 3Cr 2.71Cr 2.61Cr 318.32Cr 4.96Cr 32Cr 13Cr 152.51Cr 13Cr 13Cr 546.88Cr | P/E ratio 2024 |
-148x | P/E ratio 2025 | -145x |
|---|---|---|---|---|---|
| Enterprise value | 4.76Cr 3.47Cr 3Cr 2.72Cr 2.61Cr 318.73Cr 4.97Cr 32Cr 13Cr 152.71Cr 13Cr 13Cr 547.57Cr | EV / Sales 2024 |
96.3x | EV / Sales 2025 | 61.7x |
| Free-Float |
30.45% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -8.00% | ||
| 1 week | -2.82% | ||
| Current month | -6.76% | ||
| 1 month | -19.77% | ||
| 3 months | -28.87% | ||
| 6 months | +58.62% | ||
| Current year | -14.81% |
| 1 week | 0.63 |  | 0.92 |
| 1 month | 0.63 | | 1 |
| Current year | 0.49 | | 1 |
| 1 year | 0.3 | | 1.1 |
| 3 years | 0.28 | | 1.15 |
| 5 years | 0.28 | | 2.72 |
| 10 years | 0.06 | | 8.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Youngsoo Kim
CEO | Chief Executive Officer | - | 24/08/2020 |
Yunji Kim
CEO | Chief Executive Officer | 43 | 01/06/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Yunji Kim
BRD | Director/Board Member | 43 | 22/10/2012 |
Marcus Kuypers
BRD | Director/Board Member | 71 | 08/07/2013 |
Terrance Owen
BRD | Director/Board Member | 79 | 08/07/2013 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.00% | -2.82% | +16.95% | -1.43% | 3.47Cr | |
| +0.03% | -2.81% | -18.13% | -38.85% | 591.48Cr | |
| +0.08% | -3.26% | -7.17% | +11.16% | 490.2Cr | |
| +0.42% | -5.09% | +36.30% | +17.24% | 404.78Cr | |
| +0.24% | -5.95% | +17.43% | -45.53% | 398.57Cr | |
| -0.47% | -0.15% | +0.18% | -4.58% | 367.94Cr | |
| +0.51% | -5.12% | -7.65% | +0.07% | 301.12Cr | |
| +0.37% | -4.18% | +8.82% | -19.80% | 249.13Cr | |
| -2.04% | +1.13% | +12.43% | +0.28% | 206.25Cr | |
| +0.52% | -0.98% | +2.95% | +34.94% | 174.23Cr | |
| Average | -0.83% | -2.98% | +6.21% | -4.65% | 318.72Cr | |
| Weighted average by Cap. | +0.01% | -3.32% | +3.30% | -9.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7L 5L 4L 4L 4L 4.7Cr 7L 47.44L 18.96L 2.25Cr 19.22L 18.81L 8.08Cr | 8L 6L 5L 4L 4L 5.24Cr 8L 52.84L 21.12L 2.51Cr 21.41L 20.95L 9Cr |
| Net income | -5L -3L -3L -3L -2L -3.05Cr -5L -30.8L -12.31L -1.46Cr -12.48L -12.21L -5.25Cr | -3L -2L -2L -2L -2L -2.23Cr -3L -22.48L -9L -1.07Cr -9L -9L -3.83Cr |
| Net Debt | 79.61T 58.05T 50.21T 45.46T 43.65T 53.31L 83.12T 5L 2L 25.54L 2L 2L 91.59L | 60.3T 43.98T 38.03T 34.44T 33.06T 40.39L 62.96T 4L 2L 19.35L 2L 2L 69.38L |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | 0.6900 $ | -8.00% | 6,560 |
| 04/26/04 | 0.7500 $ | -6.25% | 1,173 |
| 03/26/03 | 0.8000 $ | -13.04% | 5,092 |
| 02/26/02 | 0.9200 $ | +24.32% | 11,515 |
| 27/26/27 | 0.7400 $ | +4.23% | 3,638 |
- Stock Market
- Equities
- EBM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition